July 06, 2018 11:45 AM
More than 1.25 million Americans have Type 1 Diabetes, according to the American Diabetes Association. There is no cure for the disease, but there are constant technological advances that can make living with the disease more manageable. One of them includes a new pump made by Minnesota-based Medtronic is referred to as the 'artificial pancreas.'
The MiniMed670G went on the market last year and was haled by the FDA for the first-of-its-kind technology that combines both a glucose monitor and an insulin pump in one device. Just last month, the FDA approved the pump for younger patients, in the age range of 7-to-13-years-old.
As of right now, about 2,000 patients have been trained and are using the new pump. Mark and Jack Donahue from Chaska are two of them.
"It does all the thinking for us," Mark Donahue said.
Mark and his 12-year-old son, Jack, were both diagnosed with Type 1 Diabetes eight years ago. They have both experimented with an array of devices and technology to help them manage the disease.
Donahue says the MiniMed 670G pump automatically monitors blood sugar levels and administers insulin as needed. No constant checking or injecting required, which is a game-changer.
"It does the calculating and it keeps you in a range that is much tighter than it ever was before, " Mark said.
"It keeps me stable. When I go high, it gives me insulin to bring me down," said Jack.
For more information on the upcoming 'Ride To Cure Diabetes,' click here.
Updated: July 06, 2018 11:45 AM
Created: June 25, 2018 02:06 PM
Copyright 2018 - KSTP-TV, LLC A Hubbard Broadcasting Company